Aridis Pharmaceuticals (ARDS) Short Interest Ratio & Short Volume $0.0001 0.00 (0.00%) As of 05/9/2025 10:51 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock Aridis Pharmaceuticals Short Interest DataAridis Pharmaceuticals (ARDS) has a short interest of 2.43 million shares. This marks a 21.50% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 8,169 shares to cover all short positions.Current Short Interest2,430,000 sharesPrevious Short Interest2,000,000 sharesChange Vs. Previous Month+21.50%Dollar Volume Sold Short$774,927.00Short Interest Ratio0.5 Days to CoverLast Record DateJuly 15, 2023Outstanding Shares53,321,000 sharesPercentage of Shares Shorted4.56%Today's Trading Volume160 sharesAverage Trading Volume8,169 sharesToday's Volume Vs. Average2% Short Selling Aridis Pharmaceuticals? Sign up to receive the latest short interest report for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartARDS Short Interest Over TimeARDS Days to Cover Over TimeARDS Percentage of Float Shorted Over Time Aridis Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/20232,430,000 shares $774,927.00 +21.5%N/A0.5 $0.32 6/30/20232,000,000 shares $439,800.00 +8.1%N/A0.6 $0.22 6/15/20231,850,000 shares $499,315.00 +320.7%N/A0.5 $0.27 5/31/2023439,700 shares $174,736.78 -41.9%N/A0.1 $0.40 5/15/2023756,200 shares $161,221.84 +87.0%N/A0.9 $0.21 4/30/2023404,400 shares $72,711.12 -29.5%N/A0.4 $0.18 4/15/2023573,300 shares $126,126.00 +0.3%N/A0.4 $0.22 3/31/2023571,400 shares $179,476.74 -81.3%N/A0.4 $0.31 3/15/20233,060,000 shares $1.27 million +323.8%N/A2 $0.41 2/28/2023722,100 shares $407,264.40 +2.6%N/A0.8 $0.56 Get the Latest News and Ratings for ARDS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aridis Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/2023703,900 shares $436,418.00 +7.6%N/A0.8 $0.62 1/31/2023654,300 shares $438,381.00 +1,125.3%N/A0.8 $0.67 1/15/202353,400 shares $68,085.00 -44.3%N/A0.2 $1.28 12/30/202295,900 shares $113,162.00 -51.1%N/A0.9 $1.18 12/15/2022196,200 shares $198,162.00 +120.0%N/A1.2 $1.01 11/30/202289,200 shares $81,172.00 -8.0%N/A0.6 $0.91 11/15/202297,000 shares $81,480.00 -7.6%N/A0.7 $0.84 10/31/2022105,000 shares $109,200.00 -49.8%N/A0.7 $1.04 10/15/2022209,000 shares $204,903.60 -55.9%N/A1 $0.98 9/30/2022473,500 shares $440,355.00 +276.7%N/A2.3 $0.93 9/15/2022125,700 shares $227,517.00 +42.2%N/A1.1 $1.81 8/31/202288,400 shares $129,064.00 -53.4%N/A0.7 $1.46 8/15/2022189,700 shares $415,443.00 +53.2%N/A1.5 $2.19 7/31/2022123,800 shares $305,786.00 +28.0%N/A1 $2.47 7/15/202296,700 shares $106,370.00 +3.5%N/A1.8 $1.10 6/30/202293,400 shares $102,740.00 -50.2%N/A1.7 $1.10 6/15/2022187,700 shares $268,411.00 +0.9%N/A2.9 $1.43 5/31/2022186,000 shares $213,900.00 +114.5%N/A2.6 $1.15 5/15/202286,700 shares $80,891.10 -20.8%N/A0.6 $0.93 4/30/2022109,500 shares $136,875.00 +52.1%N/A0.3 $1.25 4/15/202272,000 shares $103,680.00 -36.3%N/A0.1 $1.44 3/31/2022113,000 shares $198,880.00 +32.0%1.2%0.1 $1.76 3/15/202285,600 shares $130,112.00 -55.0%0.9%0 $1.52 2/28/2022190,000 shares $380,000.00 -77.5%2.0%0.1 $2.00 2/15/2022844,900 shares $2.07 million -67.6%8.9%0.4 $2.45 1/31/20222,610,000 shares $4.72 million +1,272.2%27.6%1.2 $1.81 1/15/2022190,200 shares $292,908.00 +45.9%2.0%0.1 $1.54 12/31/2021130,400 shares $303,832.00 +3,004.8%1.4%0.1 $2.33 12/15/20214,200 shares $9,156.00 -82.1%0.0%0 $2.18 11/30/202123,500 shares $53,110.00 +360.8%0.3%0.7 $2.26This next market event could mean total financial ruin for some (Ad)You think the volatility is over? Think again … Because it’s just getting started. In fact, according to a strange investment secret discovered just before the Great Depression …Including the list of five stocks you should absolutely avoid … Click here now — before it’s too la 11/15/20215,100 shares $14,229.00 -67.1%0.1%0.2 $2.79 10/29/202115,500 shares $54,250.00 -49.7%0.2%0.4 $3.50 10/15/202130,800 shares $108,416.00 -53.5%0.4%0.5 $3.52 9/30/202166,200 shares $243,616.00 +13.0%0.9%0.4 $3.68 9/15/202158,600 shares $234,400.00 -0.9%0.8%0.4 $4.00 8/31/202159,100 shares $237,582.00 +7.1%0.8%0.4 $4.02 8/13/202155,200 shares $212,520.00 +38.7%0.8%0.3 $3.85 7/30/202139,800 shares $198,602.00 +54.9%0.6%0.3 $4.99 7/15/202125,700 shares $147,004.00 +10.8%0.3%0.2 $5.72 6/30/202123,200 shares $171,680.00 +35.7%0.3%1 $7.40 6/15/202117,100 shares $123,462.00 +11.8%0.2%0.9 $7.22 5/28/202115,300 shares $88,434.00 -32.3%0.2%0.6 $5.78 5/14/202122,600 shares $141,250.00 +43.0%0.3%0.8 $6.25 4/30/202115,800 shares $98,501.94 -8.7%0.2%0.5 $6.23 4/15/202117,300 shares $101,032.00 -22.8%0.2%0.5 $5.84 3/31/202122,400 shares $128,800.00 +63.5%0.3%0.7 $5.75 3/15/202113,700 shares $105,764.00 +61.2%0.2%0.5 $7.72 2/26/20218,500 shares $52,360.00 -30.9%0.1%0.4 $6.16 2/12/202112,300 shares $97,785.00 +66.2%0.2%0.6 $7.95 1/29/20217,400 shares $48,766.00 -9.8%0.1%0.5 $6.59 1/15/20218,200 shares $57,236.00 +64.0%0.1%0.6 $6.98 12/31/20205,000 shares $30,550.00 -12.3%0.1%0.4 $6.11 12/15/20205,700 shares $43,776.00 -31.3%0.1%0.5 $7.68 11/30/20208,300 shares $56,676.55 -27.8%0.1%0.7 $6.83 11/15/202011,500 shares $81,650.00 +38.6%0.2%1 $7.10 10/30/20208,300 shares $53,784.00 -83.2%0.1%0.7 $6.48 10/15/202049,400 shares $366,552.94 -17.3%0.8%4.3 $7.42 9/30/202059,700 shares $422,676.00 +911.9%1.2%5.3 $7.08 9/15/20205,900 shares $42,952.00 -45.4%0.1%0.5 $7.28 8/31/202010,800 shares $75,600.00 -57.7%0.2%1 $7.00 8/14/202025,500 shares $163,455.00 -3.0%0.5%2.5 $6.41 7/31/202026,300 shares $184,100.00 +0.4%0.5%2.6 $7.00 7/15/202026,200 shares $185,496.00 -6.1%0.5%2.5 $7.08 6/30/202027,900 shares $183,861.00 +8.1%0.5%3.5 $6.59 6/15/202025,800 shares $165,120.00 -7.2%0.5%3.5 $6.40 5/29/202027,800 shares $178,198.00 -27.4%0.5%4.3 $6.41 5/15/202038,300 shares $266,951.00 -3.5%0.7%6.5 $6.97 ARDS Short Interest - Frequently Asked Questions What is Aridis Pharmaceuticals' current short interest? Short interest is the volume of Aridis Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 15th, traders have sold 2,430,000 shares of ARDS short. Learn More on Aridis Pharmaceuticals' current short interest. Is Aridis Pharmaceuticals' short interest increasing or decreasing? Aridis Pharmaceuticals saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 2,430,000 shares, an increase of 21.5% from the previous total of 2,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($3.75 billion), Charter Communications, Inc. ($3.17 billion), Occidental Petroleum Co. ($2.86 billion), Rivian Automotive, Inc. ($2.29 billion), T. Rowe Price Group, Inc. ($2.13 billion), Royal Caribbean Cruises Ltd. ($2.05 billion), Palantir Technologies Inc. ($2.04 billion), Extra Space Storage Inc. ($1.98 billion), Enphase Energy, Inc. ($1.66 billion), and Tractor Supply ($1.61 billion). View all of the most shorted stocks. What does it mean to sell short Aridis Pharmaceuticals stock? Short selling ARDS is an investing strategy that aims to generate trading profit from Aridis Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aridis Pharmaceuticals? A short squeeze for Aridis Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ARDS, which in turn drives the price of the stock up even further. How often is Aridis Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARDS, twice per month. The most recent reporting period available is July, 15 2023. More Short Interest Resources from MarketBeat Related Companies Alvotech Short Interest BriaCell Therapeutics Short Interest Clene Short Interest enGene Short Interest Fortress Biotech Short Interest Immatics Short Interest Jasper Therapeutics Short Interest Lexaria Bioscience Short Interest Lixte Biotechnology Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ARDS) was last updated on 5/12/2025 by MarketBeat.com Staff From Our PartnersThis next market event could mean total financial ruin for someYou think the volatility is over? Think again … Because it’s just getting started. In fact, according...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredThe Man I Turn to In Times Like ThisA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Warns “America Is Broke”. Trump’s Plan Inside.Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aridis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aridis Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
